drugset / Trial / NCT00004763

Phase II Randomized Study of Leuprolide Vs Oral Contraceptive Therapy Vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism

NCT00004763

RandomizedTreatment

Summary

OBJECTIVES: I. Evaluate the beneficial effects of leuprolide depot, oral contraceptive therapy, and leuprolide/oral contraceptive therapy in the management of patients with ovarian hyperandrogenism.

Timeline

Start
1993-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ethinyl estradiol/norethindrone Unknown Oral
Subject Leuprolide Other / unclassified Intramuscular

Indications

No indication recorded.